Webinar live date: Thursday 23 July 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion. The panel discussion focuses on new methods, the new age of biomarkers and current trends in non-standard bioanalytical techniques.
Webinar live date: Wednesday 29 July 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. This webinar will discuss how multi-parameter flow cytometry can be used to confidently detect, characterizeand quantitate rare-cell populations for clinical development applications.
Read expert answers to audience submitted questions during the recent panel discussion – COVID-19 and patient-centric sampling: how to fight a pandemic.
Webinar date: Wednesday 15th July 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Join us for an in-depth bioanalytical and clinical exploration, including case studies, of microsampling technology and its significance in supporting patient-centric healthcare initiatives.
Wednesday 8 July 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST] – register now. In this webinar, we will investigate ligand binding assays (LBAs) and LC–MS/MS generic PK methods for the quantification of therapeutic monoclonal antibodies in pre-clinical species.
Panel discussion available on demand. In this free panel discussion, our experts will provide insights into their own research and involvement with biomarker discovery including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.
Webinar available on demand. Learn how LC–MS/MS targeted quantification approaches can provide the highest possible sensitivity and selectivity for host cell proteins for biotherapeutic production.
Webinar available on demand. As COVID-19 is shutting down countries, particularly locking down travel, we discuss the impact on blood sample collection and how a patient-centric sampling approach could help mitigate these challenges and how the approach could be part of our new normal.
Webinar available on demand. Development and optimization of a fit-for-purpose, fully qualified biotherapeutic PK assay on a microfluidic, automated immunoassay platform enhances workflow efficiency and minimizes human error.
Webinar available on demand. With the ongoing COVID-19 pandemic extensively impacting clinical trials irrespective of indication, learn how bioequivalence studies (BCS) can be a suitable stop-gap measure in the interim.
Webinar available on demand. We discuss the translation of a diagnostic virus neutralization method to a quantitative relative potency for an anti-viral antibody, using the example of an anti-influenza antibody.
Webinar available on demand. Join Frontage Laboratories, Inc. (MA, USA) for the presentation of ‘Biomarker bioanalysis support to drug development and personalized medicine’.
Researchers Julius-Maximilians-Universität (JMU; Würzburg, Germany), the University of Geneva (Geneva, Switzerland) and Monash University (Melbourne, Australia) have been able to create fluorescence imagining with molecular resolution to image cell structures, for the first time, by combining two previously incompatible microscopy methods.
SCIEX (MA, USA), a global leader in life science analytical technology, recently announced the launch of the next generation of their flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready.
Trajan Scientific and Medical (Melbourne, Australia) has listed its hemaPEN® blood microsampling device with the US FDA as Class I for therapeutic and in vitro diagnostic use.
Metabolomics expert Martin Giera (Head of the Metabolomics Group at the Leiden University Medical Center) tells us about some of the latest metabolomics developments. Is it possible that activity metabolomics could shape our future understanding of biology? Learn more.